E3-ubiquitin ligase Cbl-b inhibitors (Progenra/Childrens Hospital of Philadelphia/University of Pennsylvania)

N/A

Report date: 2025/03/18 18:13:02
NME

Base Information

Drug NameE3-ubiquitin ligase Cbl-b inhibitors (Progenra/Childrens Hospital of Philadelphia/University of Pennsylvania)
Drug Alias NameCbl-b checkpoint inhibitor (Progenra/Childrens Hospital of Philadelphia/University of Pennsylvania)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionE3 ubiquitin-protein ligase CBL-B inhibitors
TargetsE3 ubiquitin-protein ligase CBL-B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProgenra Inc
China Registration ClassN/A

Develop Information

Active CompaniesChildrens Hospital of PhiladelphiaProgenra IncUniversity Of Pennsylvania
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A